UK-432097

a highly potent and selective agonist and drug candidate for chronic obstructive pulmonary disease (COPD) treatment; structure in first source

Also Known As:

2-(3-(1-(pyridin-2-yl)piperidin-4-yl)ureido)ethyl-6-N-(2,2-diphenylethyl)-5'-N-ethylcarboxamidoadenosine-2-carboxamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Allergic Rhinitis 01/01/2010 - "Adenosine A(2A) receptor agonists have been assessed as topical agents: GW328267X (GSK; allergic rhinitis and asthma), UK-432097 (Pfizer; chronic obstructive pulmonary disease [COPD]) and Sonedenoson (MRE0094, King Pharmaceuticals; wound healing). "
2.	Chronic Obstructive Pulmonary Disease (COPD) 01/01/2010 - "Adenosine A(2A) receptor agonists have been assessed as topical agents: GW328267X (GSK; allergic rhinitis and asthma), UK-432097 (Pfizer; chronic obstructive pulmonary disease [COPD]) and Sonedenoson (MRE0094, King Pharmaceuticals; wound healing). "
3.	Asthma (Bronchial Asthma) 01/01/2010 - "Adenosine A(2A) receptor agonists have been assessed as topical agents: GW328267X (GSK; allergic rhinitis and asthma), UK-432097 (Pfizer; chronic obstructive pulmonary disease [COPD]) and Sonedenoson (MRE0094, King Pharmaceuticals; wound healing). "

1.	Adenosine A2A Receptor (Adenosine A2A Receptors)
2.	2-(2-(4-chlorophenyl)ethoxy)adenosine